Deep Medicine Acquisition (Deep Medicine Acquisition) Pretax Margin % : % (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Deep Medicine Acquisition Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Deep Medicine Acquisition's Pre-Tax Income for the three months ended in Sep. 2023 was $-0.27 Mil. Deep Medicine Acquisition's Revenue for the three months ended in Sep. 2023 was $0.00 Mil. Therefore, Deep Medicine Acquisition's pretax margin for the quarter that ended in Sep. 2023 was %.

The historical rank and industry rank for Deep Medicine Acquisition's Pretax Margin % or its related term are showing as below:

DMAQ's Pretax Margin % is not ranked ^*
in the Diversified Financial Services industry.
Industry Median: 5.2
* Ranked among companies with meaningful Pretax Margin % only.

Deep Medicine Acquisition Pretax Margin % Historical Data

The historical data trend for Deep Medicine Acquisition's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deep Medicine Acquisition Pretax Margin % Chart

Deep Medicine Acquisition Annual Data

Trend

Mar21

Mar22

Mar23

Pretax Margin %

Deep Medicine Acquisition Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Pretax Margin %	Get a 7-Day Free Trial							-	-	-	-	-

Competitive Comparison of Deep Medicine Acquisition's Pretax Margin %

For the Shell Companies subindustry, Deep Medicine Acquisition's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Deep Medicine Acquisition's Pretax Margin % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Deep Medicine Acquisition's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Deep Medicine Acquisition's Pretax Margin % falls into.

Deep Medicine Acquisition Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Deep Medicine Acquisition's Pretax Margin for the fiscal year that ended in Mar. 2023 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	-0.343	/	0
	=	%

Deep Medicine Acquisition's Pretax Margin for the quarter that ended in Sep. 2023 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	-0.27	/	0
	=	%

Deep Medicine Acquisition (NAS:DMAQ) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Deep Medicine Acquisition Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Deep Medicine Acquisition's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Deep Medicine Acquisition (Deep Medicine Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Deep Medicine Acquisition Corp (NAS:DMAQ) » Definitions » Pretax Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

595 Madison Avenue, 12th Floor, New York, NY, USA, 10017

Website

Deep Medicine Acquisition Corp is a blank check company.

Executives

John Chiang	director	3538 TORRANCE BLVD., UNIT 177, TORRANCE CA 90503
Bryant Fong	director	2170 VALLEJO STREET #101, SAN FRANCISCO CA 94123
Humphrey P Polanen	director, officer: Chief Executive Officer	C/O HERITAGE COMMERCE CORP, 150 ALMADEN BLVD, SAN JOSE CA 95113
Weixuan Luo	officer: Chief Financial Officer	40 WALL STREET, 29TH FLOOR, NEW YORK NY 10005
Marc Hamer	director	7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Bright Vision Sponsor Llc	10 percent owner	7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Ronald M. Razmi	director	7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Hongliang Ren	director	7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Wanlei Miao	director	595 MADISON AVENUE, 12TH FLOOR, NEW YORK NY 10017
Tina Spires	director	595 MADISON AVENUE, 12TH FLOOR, NEW YORK NY 10017